Reporting-line record
Cytokinetics: the CISO briefs the Audit Committee alongside the CEO and CFO
Cytokinetics' 2025 Form 10-K states its Chief Information Security Officer, CEO and CFO together brief the Audit Committee on cybersecurity risk.
Cytokinetics, Incorporated's Item 1C Cybersecurity disclosure, in its Form 10-K for the fiscal year ended December 31, 2025, filed February 26, 2026, gives the Audit Committee the lead board-level role for cybersecurity oversight and names three executives, not the Chief Information Security Officer alone, as the management voice into that committee.
The filing states that the Chief Information Security Officer, Chief Executive Officer and Chief Financial Officer together play this role, providing cybersecurity briefings to the Audit Committee on a regular basis.
This is a joint-briefing structure, distinct from a single stated reporting line to one executive: the filing does not separately say which, if any, of the three the Chief Information Security Officer reports to day to day. This record states only what the filing says; see the network's reporting-line record for how other companies describe theirs, with no comparison or ranking implied.